93 related articles for article (PubMed ID: 16321443)
1. The use of tetrathiomolybdate in treating fibrotic, inflammatory, and autoimmune diseases, including the non-obese diabetic mouse model.
Brewer GJ; Dick R; Zeng C; Hou G
J Inorg Biochem; 2006 May; 100(5-6):927-30. PubMed ID: 16321443
[TBL] [Abstract][Full Text] [Related]
2. Anticopper therapy against cancer and diseases of inflammation and fibrosis.
Brewer GJ
Drug Discov Today; 2005 Aug; 10(16):1103-9. PubMed ID: 16182195
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of key cytokines by tetrathiomolybdate in the bleomycin model of pulmonary fibrosis.
Brewer GJ; Dick R; Ullenbruch MR; Jin H; Phan SH
J Inorg Biochem; 2004 Dec; 98(12):2160-7. PubMed ID: 15541506
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of tetrathiomolybdate in a mouse model of multiple sclerosis.
Hou G; Abrams GD; Dick R; Brewer GJ
Transl Res; 2008 Nov; 152(5):239-44. PubMed ID: 19010295
[TBL] [Abstract][Full Text] [Related]
5. Tetrathiomolybdate therapy protects against bleomycin-induced pulmonary fibrosis in mice.
Brewer GJ; Ullenbruch MR; Dick R; Olivarez L; Phan SH
J Lab Clin Med; 2003 Mar; 141(3):210-6. PubMed ID: 12624602
[TBL] [Abstract][Full Text] [Related]
6. Comparison of lowering copper levels with tetrathiomolybdate and zinc on mouse tumor and doxorubicin models.
Hou G; Dick R; Zeng C; Brewer GJ
Transl Res; 2006 Dec; 148(6):309-14. PubMed ID: 17162252
[TBL] [Abstract][Full Text] [Related]
7. Improvement in dissolution of liver fibrosis in an animal model by tetrathiomolybdate.
Hou G; Dick R; Brewer GJ
Exp Biol Med (Maywood); 2009 Jun; 234(6):662-5. PubMed ID: 19307461
[TBL] [Abstract][Full Text] [Related]
8. Tetrathiomolybdate therapy protects against concanavalin a and carbon tetrachloride hepatic damage in mice.
Askari FK; Dick R; Mao M; Brewer GJ
Exp Biol Med (Maywood); 2004 Sep; 229(8):857-63. PubMed ID: 15337842
[TBL] [Abstract][Full Text] [Related]
9. Antitumor and antiinflammatory effects of tetrathiotungstate in comparison with tetrathiomolybdate.
Hou G; Dick R; Zeng C; Brewer GJ
Transl Res; 2007 May; 149(5):260-4. PubMed ID: 17466925
[TBL] [Abstract][Full Text] [Related]
10. Tetrathiomolybdate protects against cardiac damage by doxorubicin in mice.
Hou G; Dick R; Abrams GD; Brewer GJ
J Lab Clin Med; 2005 Nov; 146(5):299-303. PubMed ID: 16242529
[TBL] [Abstract][Full Text] [Related]
11. Tetrathiomolybdate is effective in a mouse model of arthritis.
McCubbin MD; Hou G; Abrams GD; Dick R; Zhang Z; Brewer GJ
J Rheumatol; 2006 Dec; 33(12):2501-6. PubMed ID: 17143984
[TBL] [Abstract][Full Text] [Related]
12. Cancer therapy with tetrathiomolybdate: antiangiogenesis by lowering body copper--a review.
Brewer GJ; Merajver SD
Integr Cancer Ther; 2002 Dec; 1(4):327-37. PubMed ID: 14664727
[TBL] [Abstract][Full Text] [Related]
13. Identification of QTLs that modify peripheral neuropathy in NOD.H2b-Pdcd1-/- mice.
Jiang F; Yoshida T; Nakaki F; Terawaki S; Chikuma S; Kato Y; Okazaki IM; Honjo T; Okazaki T
Int Immunol; 2009 May; 21(5):499-509. PubMed ID: 19261693
[TBL] [Abstract][Full Text] [Related]
14. Lessons on autoimmune diabetes from animal models.
Yang Y; Santamaria P
Clin Sci (Lond); 2006 Jun; 110(6):627-39. PubMed ID: 16689681
[TBL] [Abstract][Full Text] [Related]
15. An early but intense cytokine production within the islets may be predictive for type 1 diabetes occurrence in the Bio Breeding (BB) rat.
Papaccio G; Graziano A; d'Aquino R; De Francesco F; Puca A; Pedullà M
J Cell Physiol; 2006 Dec; 209(3):1016-20. PubMed ID: 16972262
[TBL] [Abstract][Full Text] [Related]
16. Tetrathiomolybdate is partially protective against hyperglycemia in rodent models of diabetes.
Zeng C; Hou G; Dick R; Brewer GJ
Exp Biol Med (Maywood); 2008 Aug; 233(8):1021-5. PubMed ID: 18480419
[TBL] [Abstract][Full Text] [Related]
17. Humanized NOD/LtSz-scid IL2 receptor common gamma chain knockout mice in diabetes research.
Shultz LD; Pearson T; King M; Giassi L; Carney L; Gott B; Lyons B; Rossini AA; Greiner DL
Ann N Y Acad Sci; 2007 Apr; 1103():77-89. PubMed ID: 17332083
[TBL] [Abstract][Full Text] [Related]
18. The virtual NOD mouse: applying predictive biosimulation to research in type 1 diabetes.
Zheng Y; Kreuwel HT; Young DL; Shoda LK; Ramanujan S; Gadkar KG; Atkinson MA; Whiting CC
Ann N Y Acad Sci; 2007 Apr; 1103():45-62. PubMed ID: 17376834
[TBL] [Abstract][Full Text] [Related]
19. Combination tetrathiomolybdate and radiation therapy in a mouse model of head and neck squamous cell carcinoma.
Khan MK; Mamou F; Schipper MJ; May KS; Kwitny A; Warnat A; Bolton B; Nair BM; Kariapper MS; Miller M; Brewer G; Normolle D; Merajver SD; Teknos TN
Arch Otolaryngol Head Neck Surg; 2006 Mar; 132(3):333-8. PubMed ID: 16549755
[TBL] [Abstract][Full Text] [Related]
20. The risks of free copper in the body and the development of useful anticopper drugs.
Brewer GJ
Curr Opin Clin Nutr Metab Care; 2008 Nov; 11(6):727-32. PubMed ID: 18827576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
